These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 5472678
21. [Acid phosphatase]. Sveinsson SL. Tidsskr Nor Laegeforen; 1970 Jan 25; 90(2):268-71. PubMed ID: 5464316 [No Abstract] [Full Text] [Related]
23. [Behavior of serum acid phosphatases following specific immunotherapy of metastasizing prostatic carcinoma]. Rothauge CF, Kraushaar J, Gutschank J, Sedlacek HH. Med Welt; 1981 Jan 09; 32(2):50-3. PubMed ID: 7207127 [No Abstract] [Full Text] [Related]
24. [Total and tartrate-inhibited acid phosphatases in serum. Significance of rectal examination in normal individuals and patients with benign prostatic hypertrophy]. Nielsen ML, Christensen P, Antoni E. Ugeskr Laeger; 1971 Nov 19; 133(46):2279-84. PubMed ID: 4109415 [No Abstract] [Full Text] [Related]
25. [Critical study of diagnostic methods of bone metastases in carcinoma of the prostate]. Netto Junior NR, Lemos GC. AMB Rev Assoc Med Bras; 1978 Jul 19; 24(7):249-50. PubMed ID: 309619 [No Abstract] [Full Text] [Related]
26. [Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase]. Bauer HW, Schüller J, Schmiedt E, Dati F. Helv Chir Acta; 1981 Aug 19; 48(3-4):459-63. PubMed ID: 7026510 [Abstract] [Full Text] [Related]
28. Acid phosphatase: clinical utility of the first tumor marker. DiPaolo CJ, Rival J. Henry Ford Hosp Med J; 1982 Aug 19; 30(2):70-6. PubMed ID: 6752100 [No Abstract] [Full Text] [Related]
29. Acid phosphatases and other tumor markers in the management of prostatic cancer. Scandinavian Committee on Enzymes, Scandinavian Prostatic Cancer Group, Workshop. Copenhagen, March 1985. Scand J Clin Lab Invest Suppl; 1985 Aug 19; 179():1-117. PubMed ID: 3866301 [No Abstract] [Full Text] [Related]
31. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer. Kuriyama M, Loor R, Wang MC, Lee C, Killian CS, Papsidero LD, Inaji H, Nishiura T, Slack NH, Murphy GP, Chu TM. Int Adv Surg Oncol; 1982 Aug 19; 5():29-49. PubMed ID: 6178696 [No Abstract] [Full Text] [Related]
32. Acid phosphatase--any value in prostatic carcinoma? Latham HS. Va Med Mon (1918); 1971 Jan 19; 98(1):47-9. PubMed ID: 5545422 [No Abstract] [Full Text] [Related]
33. [RIA of acid phosphatases--value in the staging of prostatic cancer]. Stackl W, Kroiss A, Marberger M. Helv Chir Acta; 1982 Aug 19; 49(3-4):455-8. PubMed ID: 7129918 [No Abstract] [Full Text] [Related]
36. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]. Perrin P, Clairet F, Fleury-Goyon MC, Durand L. J Urol (Paris); 1984 Aug 19; 90(1):19-22. PubMed ID: 6202800 [Abstract] [Full Text] [Related]
37. Clinical applications of various methodologies for measuring S-acid phosphatases. An inquiry by the Scandinavian Prostatic Cancer Group (SPCG). Rasmussen F. Scand J Clin Lab Invest Suppl; 1985 Aug 19; 179():19-24. PubMed ID: 3866305 [No Abstract] [Full Text] [Related]
39. [The value of counterimmunoelectrophoresis for the assay of prostatic acid phosphatase]. Lamy S, Borsi C, Humbel R. Acta Urol Belg; 1983 Aug 19; 51(3):340-4. PubMed ID: 6624623 [No Abstract] [Full Text] [Related]